Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134251
Status:
COMPLETED
Last Update Posted:
2009-01-30
First Post:
2005-08-22
Brief Title:
Ascending Dose TolerabilitySafety of SLV308 for the Treatment of Parkinsons Disease
Sponsor:
Solvay Pharmaceuticals
Organization:
Solvay Pharmaceuticals